Andreasson, U., Lautner, R., Schott, J. M., Mattsson, N., Hansson, O., Herukka, S. K., et al. (2013). CSF biomarkers for Alzheimer’s pathology and the effect size of APOE varepsilon4. Molecular Psychiatry. doi:10.1038/mp.2013.18.
PubMed Central
PubMed
Google Scholar
Baig, S., Joseph, S. A., Tayler, H., Abraham, R., Owen, M. J., Williams, J., et al. (2010). Distribution and expression of picalm in Alzheimer disease. Journal of Neuropathology and Experimental Neurology,
69(10), 1071–1077. (Research Support, Non-U.S. Gov’t).
CAS
Article
PubMed Central
PubMed
Google Scholar
Barrachina, M., Maes, T., Buesa, C., & Ferrer, I. (2006). Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer’s disease. Neuropathology and Applied Neurobiology,
32(5), 505–516.
CAS
Article
PubMed
Google Scholar
Bateman, R. J., Xiong, C., Benzinger, T. L., Fagan, A. M., Goate, A., Fox, N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. New England Journal of Medicine,
367(9), 795–804.
CAS
Article
PubMed Central
PubMed
Google Scholar
Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., & Davidsson, P. (1996). Synaptic pathology in Alzheimer’s disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. Journal of Neural Transmission,
103(5), 603–618.
CAS
Article
PubMed
Google Scholar
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006). Alzheimer’s disease. Lancet,
368(9533), 387–403.
CAS
Article
PubMed
Google Scholar
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology,
6(3), 131–144.
CAS
Article
PubMed
Google Scholar
Blennow, K., Wallin, A., Agren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995). Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease? Molecular and Chemical Neuropathology,
26(3), 231–245.
CAS
Article
PubMed
Google Scholar
Boland, B., & Nixon, R. A. (2006). Neuronal macroautophagy: From development to degeneration. Molecular Aspects of Medicine,
27(5–6), 503–519.
CAS
Article
PubMed
Google Scholar
Bronfman, F. C., Escudero, C. A., Weis, J., & Kruttgen, A. (2007). Endosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases. Dev Neurobiol,
67(9), 1183–1203.
CAS
Article
PubMed
Google Scholar
Cataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997). Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: Neuropathologic evidence for a mechanism of increased β-amyloidogenesis. Journal of Neuroscience,
17(16), 6142–6151.
CAS
PubMed
Google Scholar
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000). Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations. American Journal of Pathology,
157(1), 277–286.
CAS
Article
PubMed
Google Scholar
Ciechanover, A., & Brundin, P. (2003). The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron,
40(2), 427–446.
CAS
Article
PubMed
Google Scholar
Davidsson, P., Bogdanovic, N., Lannfelt, L., & Blennow, K. (2001). Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders,
12(4), 243–250.
CAS
Article
PubMed
Google Scholar
Delcroix, J. D., Valletta, J. S., Wu, C., Hunt, S. J., Kowal, A. S., & Mobley, W. C. (2003). NGF signaling in sensory neurons: Evidence that early endosomes carry NGF retrograde signals. Neuron,
39(1), 69–84.
CAS
Article
PubMed
Google Scholar
Ginsberg, S. D., Mufson, E. J., Counts, S. E., Wuu, J., Alldred, M. J., Nixon, R. A., et al. (2010). Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer’s disease. Journal of Alzheimer’s Disease,
22(2), 631–639.
CAS
PubMed Central
PubMed
Google Scholar
Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., et al. (2004). Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: A comparative cerebrospinal fluid study. Archives of General Psychiatry,
61(1), 95–102.
CAS
Article
PubMed
Google Scholar
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurology,
5(3), 228–234.
CAS
Article
PubMed
Google Scholar
Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science,
297(5580), 353–356.
CAS
Article
PubMed
Google Scholar
Hu, Y., Malone, J. P., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2005). Comparative proteomic analysis of intra-and interindividual variation in human cerebrospinal fluid. Molecular and Cellular Proteomics,
4(12), 2000–2009.
CAS
Article
PubMed
Google Scholar
Hua, C. T., Hopwood, J. J., Carlsson, S. R., Harris, R. J., & Meikle, P. J. (1998). Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clinical Chemistry,
44(10), 2094–2102.
CAS
PubMed
Google Scholar
Ihara, Y., Morishima-Kawashima, M., & Nixon, R. (2012). The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(8), a006361.
Google Scholar
Jiang, Y., Mullaney, K. A., Peterhoff, C. M., Che, S., Schmidt, S. D., Boyer-Boiteau, A., et al. (2010). Alzheimer’s-related endosome dysfunction in down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition. Proceedings of the National Academy of Sciences U S A,
107(4), 1630–1635.
CAS
Article
Google Scholar
Kågedal, K., Kim, W. S., Appelqvist, H., Chan, S., Cheng, D., Agholme, L., et al. (2010). Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer’s disease. Biochimica et Biophysica Acta,
1801(8), 831–838.
Article
PubMed
Google Scholar
Klionsky, D. J., Cregg, J. M., Dunn, W. A., Jr, Emr, S. D., Sakai, Y., Sandoval, I. V., et al. (2003). A unified nomenclature for yeast autophagy-related genes. Developmental Cell,
5(4), 539–545.
CAS
Article
PubMed
Google Scholar
Lipinski, M. M., Zheng, B., Lu, T., Yan, Z., Py, B. F., Ng, A., et al. (2010). Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer’s disease. Proceedings of the National Academy of Sciences USA,
107(32), 14164–14169.
CAS
Article
Google Scholar
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., et al. (2010). Decreased clearance of CNS β-amyloid in Alzheimer’s disease. Science,
330(6012), 1774.
CAS
Article
PubMed Central
PubMed
Google Scholar
Nixon, R. A., Mathews, P. M., & Cataldo, A. M. (2001). The neuronal endosomal-lysosomal system in Alzheimer’s disease. Journal of Alzheimer’s Disease,
3(1), 97–107.
CAS
PubMed
Google Scholar
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., et al. (2005). Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. Journal of Neuropathology and Experimental Neurology,
64(2), 113–122.
PubMed
Google Scholar
Perez, A., Morelli, L., Cresto, J. C., & Castano, E. M. (2000). Degradation of soluble amyloid β-peptides 1–40, 1–42, and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochemical Research,
25(2), 247–255.
CAS
Article
PubMed
Google Scholar
Schwagerl, A. L., Mohan, P. S., Cataldo, A. M., Vonsattel, J. P., Kowall, N. W., & Nixon, R. A. (1995). Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. Journal of Neurochemistry,
64(1), 443–446.
CAS
Article
PubMed
Google Scholar
Sonnen, J. A., Montine, K. S., Quinn, J. F., Kaye, J. A., Breitner, J. C., & Montine, T. J. (2008). Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol,
7(8), 704–714.
CAS
Article
PubMed Central
PubMed
Google Scholar
Sundelöf, J., Sundstrom, J., Hansson, O., Eriksdotter-Jonhagen, M., Giedraitis, V., Larsson, A., et al. (2010). Higher cathepsin B levels in plasma in Alzheimer’s disease compared to healthy controls. Journal of Alzheimer’s Disease,
22(4), 1223–1230.
PubMed
Google Scholar
Sze, C. I., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2000). Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains. Journal of the Neurological Sciences,
175(2), 81–90.
CAS
Article
PubMed
Google Scholar
Terry, R. D., Gonatas, N. K., & Weiss, M. (1964). Ultrastructural studies in Alzheimer’s presenile dementia. American Journal of Pathology,
44, 269–297.
CAS
PubMed
Google Scholar
Upadhya, S. C., & Hegde, A. N. (2007). Role of the ubiquitin proteasome system in Alzheimer’s disease. BMC Biochemistry,
8(Suppl 1), S12.
Article
PubMed Central
PubMed
Google Scholar
Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., van de Voorde, A., Martin, J. J., et al. (1993). Detection of tau proteins in normal and Alzheimer’s disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. Journal of Neurochemistry,
61(5), 1828–1834.
CAS
Article
PubMed
Google Scholar
Vanderstichele, H., Van Kerschaver, E., Hesse, C., Davidsson, P., Buyse, M. A., Andreasen, N., et al. (2000). Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid,
7(4), 245–258.
CAS
Article
PubMed
Google Scholar
Vanmechelen, E., Vanderstichele, H., Davidsson, P., Van Kerschaver, E., Van Der Perre, B., Sjogren, M., et al. (2000). Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization. Neuroscience Letters,
285(1), 49–52.
CAS
Article
PubMed
Google Scholar
Yang, D. S., Kumar, A., Stavrides, P., Peterson, J., Peterhoff, C. M., Pawlik, M., et al. (2008). Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer’s disease. American Journal of Pathology,
173(3), 665–681.
CAS
Article
PubMed
Google Scholar
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J. H., et al. (2005). Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer’s disease. Journal of Cell Biology,
171(1), 87–98.
CAS
Article
PubMed
Google Scholar
Zetterberg, H., Wahlund, L. O., & Blennow, K. (2003). Cerebrospinal fluid markers for prediction of Alzheimer’s disease. Neuroscience Letters,
352(1), 67–69.
CAS
Article
PubMed
Google Scholar
Zougman, A., Pilch, B., Podtelejnikov, A., Kiehntopf, M., Schnabel, C., Kumar, C., et al. (2008). Integrated analysis of the cerebrospinal fluid peptidome and proteome. Journal of Proteome Research,
7(1), 386–399.
CAS
Article
PubMed
Google Scholar